Study on Communication Between Patients and Providers About Immunotherapy for Cancer

What this Trial Is About

This research aims to explore communication challenges between patients and healthcare providers during discussions about immunotherapy. It focuses on understanding where patients learn about immunotherapy, their comprehension of it, how healthcare professionals explain it, and how educational videos might improve patient knowledge. The study assesses misconceptions and preferences related to immunotherapy information in people with hematopoietic and lymphoid system neoplasms or malignant solid neoplasms. Participants and their healthcare providers will be observed during a conversation about immunotherapy. Following this, participants will take part in a 20-minute interview to discuss their understanding. Additionally, participants will watch an educational video designed to explain immunotherapy, and their comprehension will be evaluated before and after viewing using a pre- and post-test method. During the study, researchers will measure misunderstandings about immunotherapy risks and benefits, patient-reported misconceptions, and preferences for information sharing. They will also track how well participants understand terms and metaphors used in these conversations. The effectiveness of the educational video will be assessed based on correct definition rates before and after watching. The total observation period may last up to four years, with ongoing assessments throughout.

Communication Issues in Patient and Provider Discussions of Immunotherapy